Sponsor of the Day:
Jerkmate
https://economictimes.indiatimes.com/markets/expert-view/sun-pharma-organon-deal-how-a-12-billion-merger-will-reshape-indias-pharma-landscape/articleshow/130570854.cms
Sun Pharma-Organon deal: How a $12-billion merger will reshape India's pharma landscape - The...
Apr 28, 2026 - Sun Pharma is set to nearly double its revenue to $12 billion with the acquisition of Organon, creating a global pharmaceutical giant. The deal leverages...
sun pharmaorganon deal12 billionreshape indiamerger
https://www.forbesindia.com/article/news/deep-dive/sun-pharmas-11-75-billion-buy-is-the-organon-deal-valuation-fair/2993503/1
Sun Pharma’s $11.75 billion buy: Is the Organon deal valuation fair?
Apr 27, 2026 - Sun Pharma acquires Organon for 11.75 billion dollars, boosting its women’s health and biosimilars presence and accelerating its shift beyond generics
11 75 billionorganon dealsunbuyvaluation
https://www.thehindubusinessline.com/portfolio/stock-fundamental-analysis-india/sun-pharma-organon-deal-outlook-is-mixed/article70912600.ece
Sun Pharma-Organon deal: Outlook is mixed - The HinduBusinessLine
Sun Pharma's acquisition of Organon doubles its footprint but presents significant growth and debt challenges ahead.
sun pharmaorganon dealoutlookmixedhindubusinessline
https://www.medtechdive.com/news/Laborie-465M-deal-buy-Jada-post-childbirth-device-Organon/805097/
Laborie inks $465M deal to buy post-childbirth device from Organon | MedTech Dive
Organon tripled sales of the bleeding-control system from 2022 to 2024 and is on track to grow sales again this year.
buy postmedtech divelaborieinksdeal
https://forbes.cz/nejvetsi-indicky-farmaceuticky-deal-v-historii-sun-kupuje-organon-za-1175-miliardy-dolaru/
Největší indický farmaceutický deal. Sun kupuje Organon za 11,75 miliardy dolarů | Forbes
za 11dealsunkupujeorganon